Kathryn A. Seely, Ph.D.
Affiliations: | 2009 | University of Arkansas for Medical Sciences, United States |
Area:
Pharmacology, Neuroscience BiologyGoogle:
"Kathryn Seely"Mean distance: 30533.1
Parents
Sign in to add mentor| Paul L. Prather | grad student | 2009 | UAMS | |
| (Cannabinoid receptor inverse agonists as novel therapeutic agents.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Patton AL, Seely KA, Yarbrough AL, et al. (2018) Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochemical and Biophysical Research Communications |
| Patton AL, Seely KA, Pulla S, et al. (2014) Quantitative measurement of acetyl fentanyl and acetyl norfentanyl in human urine by LC-MS/MS. Analytical Chemistry. 86: 1760-6 |
| Seely KA, Patton AL, Moran CL, et al. (2013) Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International. 233: 416-22 |
| Patton AL, Seely KA, Chimalakonda KC, et al. (2013) Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Analytical Chemistry. 85: 9390-9 |
| Koryakina Y, Jones SM, Cornett LE, et al. (2012) Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms. Cell Biology International. 36: 1171-83 |
| Chimalakonda KC, Seely KA, Bratton SM, et al. (2012) Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 2174-84 |
| Seely KA, Brents LK, Franks LN, et al. (2012) AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies Neuropharmacology. 63: 905-915 |
| Seely KA, Lapoint J, Moran JH, et al. (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39: 234-43 |
| Seely KA, Brents LK, Radominska-Pandya A, et al. (2012) A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors. Chemical Research in Toxicology. 25: 825-7 |
| Brents LK, Medina-Bolivar F, Seely KA, et al. (2012) Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 42: 139-56 |